Patent · US Active

Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies

US8598316B2 · kind B2 · utility

3Cited by
12References
43Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 26, 2010
Grant dateDec 3, 2013
Priority date
Expiry dateSep 25, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a conjugate that contains a therapeutic moiety linked to a homing peptide or peptidomimetic which selectively homes to vasculature of pre-malignant dysplastic skin and which includes the amino acid sequence SRPRR (SEQ ID NO: 1) or a conservative variant or peptidomimetic thereof. The present invention further provides a conjugate containing a therapeutic moiety linked to a homing peptide or peptidomimetic which selectively homes to vasculature of malignant skin and which includes the amino acid sequence CGKRK (SEQ ID NO: 6) or the amino acid sequence CDTRL (SEQ ID NO: 7), or a conservative variant or peptidomimetic of one of these sequences.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.